Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 1
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
A novel ACE2 decoy for both neutralization of SARS-CoV-2 variants and killing of infected cells.
Kegler A, Drewitz L, Arndt C, Daglar C, Rodrigues Loureiro L, Mitwasi N, Neuber C, González Soto KE, Bartsch T, Baraban L, Ziehr H, Heine M, Nieter A, Moreira-Soto A, Kühne A, Drexler JF, Seliger B, Laube M, Máthé D, Pályi B, Hajdrik P, Forgách L, Kis Z, Szigeti K, Bergmann R, Feldmann A, Bachmann M. Kegler A, et al. Among authors: gonzalez soto ke. Front Immunol. 2023 Jun 13;14:1204543. doi: 10.3389/fimmu.2023.1204543. eCollection 2023. Front Immunol. 2023. PMID: 37383226 Free PMC article.
Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells.
Saleh HA, Mitwasi N, Ullrich M, Kubeil M, Toussaint M, Deuther-Conrad W, Neuber C, Arndt C, R Loureiro L, Kegler A, González Soto KE, Belter B, Rössig C, Pietzsch J, Frenz M, Bachmann M, Feldmann A. Saleh HA, et al. Among authors: gonzalez soto ke. Front Immunol. 2023 Apr 14;14:1166169. doi: 10.3389/fimmu.2023.1166169. eCollection 2023. Front Immunol. 2023. PMID: 37122703 Free PMC article.
Development and Functional Characterization of a Versatile Radio-/Immunotheranostic Tool for Prostate Cancer Management.
Arndt C, Bergmann R, Striese F, Merkel K, Máthé D, Loureiro LR, Mitwasi N, Kegler A, Fasslrinner F, González Soto KE, Neuber C, Berndt N, Kovács N, Szöllősi D, Hegedűs N, Tóth G, Emmermann JP, Harikumar KB, Kovacs T, Bachmann M, Feldmann A. Arndt C, et al. Among authors: gonzalez soto ke. Cancers (Basel). 2022 Apr 14;14(8):1996. doi: 10.3390/cancers14081996. Cancers (Basel). 2022. PMID: 35454902 Free PMC article.
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy.
Feldmann A, Hoffmann A, Bergmann R, Koristka S, Berndt N, Arndt C, Rodrigues Loureiro L, Kittel-Boselli E, Mitwasi N, Kegler A, Lamprecht C, González Soto KE, Bachmann M. Feldmann A, et al. Among authors: gonzalez soto ke. Oncoimmunology. 2020 Jul 3;9(1):1785608. doi: 10.1080/2162402X.2020.1785608. Oncoimmunology. 2020. PMID: 32923149 Free PMC article.
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma.
Köseer AS, Loureiro LR, Jureczek J, Mitwasi N, González Soto KE, Aepler J, Bartsch T, Feldmann A, Kunz-Schughart LA, Linge A, Krause M, Bachmann M, Arndt C, Dubrovska A. Köseer AS, et al. Among authors: gonzalez soto ke. Cancers (Basel). 2022 Mar 25;14(7):1677. doi: 10.3390/cancers14071677. Cancers (Basel). 2022. PMID: 35406454 Free PMC article.
Targeting Acute Myeloid Leukemia Using the RevCAR Platform: A Programmable, Switchable and Combinatorial Strategy.
Kittel-Boselli E, Soto KEG, Loureiro LR, Hoffmann A, Bergmann R, Arndt C, Koristka S, Mitwasi N, Kegler A, Bartsch T, Berndt N, Altmann H, Fasslrinner F, Bornhäuser M, Bachmann MP, Feldmann A. Kittel-Boselli E, et al. Among authors: soto keg. Cancers (Basel). 2021 Sep 24;13(19):4785. doi: 10.3390/cancers13194785. Cancers (Basel). 2021. PMID: 34638268 Free PMC article.